share_log

百洋医药(301015.SZ):2023年度净利润6.56亿元 拟10派7.62元

Baiyang Pharmaceutical (301015.SZ): 2023 net profit of 656 million yuan, plans to distribute 10 to 7.62 yuan

Gelonghui Finance ·  Apr 22 04:37

Gelonghui, April 22丨Baiyang Pharmaceutical (301015.SZ) announced its 2023 annual report. Operating income for the reporting period was 7.564 billion yuan, up 0.72% year on year; net profit attributable to shareholders of listed companies was 656 million yuan, up 29.55% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 635 million yuan, up 25.14% year on year; basic income per share was 1.25 yuan; it plans to pay a cash dividend of 7.62 yuan (tax included) for every 10 shares to all shareholders.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment